Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes

Kidney International

Volumn 51, Issue 1, 1997, Pages 119-124

  Miller, Judith A ^a,b   Scholey, James W ^a   Thai, Kerri ^a   Pei, York P C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; ENZYME POLYMORPHISM; FEMALE; HUMAN; KIDNEY BLOOD FLOW; MALE; PRIORITY JOURNAL;

EID: 0031048211     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.15     Document Type: Article

References (38)

1. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
2. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU J-P, ARVEILER D, LUC G, BARD J-M, AMOUYE P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
3. NAKAI K, ITOH C, MIURA Y, HOTTA K, MUSHA T, ITOH T, MIYAKAWA T, IWASAKI R, HIRAMORI K: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 90:2199-2202, 1994
4. MARRE M, BERNADET P, GALLOIS Y, SAVAGNER F, GUYENE T-T, HALLAB M, CAMBIEN F, PASSA P, ALHENC-GELAS F: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
5. DORIA A, WARRAM JH, KROLEWSKI AS: Genetic predisposition to diabetic nephropathy: Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43:690-695, 1994
6. SCHMIDT S, SCHÖNE N, RITZ E, DIABETIC NEPHROPATHY STUDY GROUP: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47:1176-1181, 1995
7. TARNOW L, CAMBIEN F, ROSSING P, NIELSEN FS, HANSEN BV, LECERF L, POIRIER O, DANILOV S, PARVING HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
8. DUDLEY CRK, KEAVNEY B, STRATTON IM, TURNER RC, RATCLIFFE PJUK: Prospective Diabetes Study XV: Relationship of renin-angiotensin gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48:1907-1911, 1995
9. BRØCHNER-MORTENSEN J, DITZEL J: Glomerular filtration rate and extracellular fluid volume in insulin-dependent patients with diabetes mellitus. Kidney Int 21:696-698, 1982
10. MILLER JA, FLORAS JS, ZINMAN B, SKORECKI KL, LOGAN AG: Abnormalities in the renal and vascular responses to LBNP in humans with early diabetes. Am J Physiol 266:R442-R450, 1994
11. HOSTETTER TH, TROY JL, BRENNER BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-415, 1981
12. ZATZ R, MEYER TW, RENNKE HG, BRENNER BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82:5963-5967, 1985
13. MOGENSEN CE: Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 46:201-206, 1986
14. RUDBERG S, PERSSON B, DAHLQUIST G: Increased glomerular filtration rate as a predictor of diabetic nephropathy-An 8-year prospective study. Kidney Int 41:822-828, 1992
15. MILLER JA: Sympathetic vasoconstrictive responses to high and low sodium diets in normal and diabetic subjects. Am J Physiol 269:R380-R388, 1995
16. WHITE NH, SKOR D, SANTIAGO JV: Practical closed-loop insulin delivery: A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med 97:210-213, 1982
17. DALTON RN, WISEMAN MJ, TURNER C, VIBERTI GC: Measurement of urinary para-amminohippuric acid in glycosuric diabetics. Kidney Int 34:117-120, 1988
18. WALSER M, DAVIDSON DG, ORLOFF J: The renal clearance of alkali-stable inulin. J Clin Invest 34:1520-1523, 1955
19. BRUN C: A rapid method for the determination of para-aminohippuric acid in kidney function tests. J Lab Clin Med 37:955-958, 1951
20. RIGAT B, HUBERT C, CORVOL P, SOUBRIER F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase). (abstract) Nucl Acid Res 20:1433, 1992
21. ANDERSON S, JUNG FF, INGELFINGER JR: Renal renin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265:F477-F486, 1993
22. WISEMAN MJ, DRURY PL, KEEN DH, VIBERTI GC: Plasma renin activity in insulin-dependent diabetics with raised glomerular filtration rate. Clin Endocrinol 21:409-414, 1984
23. SOLERTE SB, FIORAVANTI M, PETRAGLIA F, FACHINETTI F, APRILE C, GENAZZANI AR, FERRARI E: Circulating opioids and plasma renin activity in insulin dependent diabetics with renal hemodynamic alterations. Nephron 46:194-198, 1987
24. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD, COLLABORATIVE STUDY GROUP: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
25. DIABETES CONTROL, COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
26. ZELLER K, WHITTAKER E, SULLIVAN L, RASKIN P, JACOBSON HR: Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 324:78-84, 1991
27. MILLER JA, FLORAS JS, ZINMAN B, SKORECKI KL, LOGAN AG: Effect of hyperglycemia on arterial pressure, plasma renin activity, and renal function in early diabetes. Clin Sci 90:189-195, 1996
28. ROSENBERG ME, CHMIELEWSKI D, HOSTETTER TH: Effect of dietary protein on rat renin and angiotensinogen gene expression. J Clin Invest 85:1144-1149, 1990
29. ROSENBERG ME, SWANSON JE, THOMAS BL, HOSTETTER TH: Glomerular and hormonal responses to dietary protein intake in human renal disease. Am J Physiol 253:F1083-F1090, 1987
30. TIRET L, RIGAT B, VISVIKIS S, BRENDA C, CORVOL P, CAMBRIEN F, SOUBRIER F: Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992
31. UEDA S, ELLIOTT HL, MORTON JJ, CONNELL JM: Enhanced pressor response to angiotensin I in normal men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25:1266-1269, 1995
32. MORISHITA R, GIBBONS GH, ELLISON KE, LEE W, ZHANG L, YU H, KANEDA Y, OGIHARA T, DZAU VJ: Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 94:978-984, 1994
33. MYERS BD, DEEN WM, BRENNER BM: Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37:101-110, 1975
34. ALLON M, PASQUE CB, RODRIGUEZ M: Interaction of captopril and ibuprofen on glomerular and tubular function in humans. Am J Physiol 259:F233-F238, 1990
35. WISEMAN MJ, SAUNDERS AJ, KEEN H, VIBERTI G-C: Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 312:617-621, 1985
36. BANK N, LAHORRA MAG, AYNEDJIAN HS, WILKES BM: Sodium restriction corrects hyperfiltration of diabetes. Am J Physiol 254:F668-F676, 1988
37. BROWN SA, FINCO DR: Characterization of the renal response to protein ingestion in dogs with experimentally induced renal failure. Am J Vet Res 53:569-573, 1992
38. 1 receptor antagonist losartan on angiotensin II induced hypertrophy of rat cardiomyocytes. (abstract) FASEB J 6:A1261, 1992